Regulus Therapeutics Inc. (RGLS)
NASDAQ: RGLS
· Real-Time Price · USD
8.16
0.00 (0.00%)
At close: Jun 24, 2025, 3:59 PM
Regulus Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 302K | 302K | 302K | 302K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 5M | 10M | 10M |
Cost of Revenue | 259K | 340K | 246K | 302K | 260K | 227K | 184K | 160K | 144K | 122K | 4.5M | 4.5M | 4.52M | 4.83M | 4.37M | 8.37M | 12.56M |
Gross Profit | 81K | n/a | 56K | n/a | 42K | 75K | -184K | -160K | -144K | -122K | -4.5M | -4.5M | -4.52M | -4.83M | 631K | 1.63M | -2.56M |
Operating Income | -51.75M | -50.04M | -44.6M | -37.51M | -32.57M | -31.11M | -29.74M | -29.18M | -29.04M | -28.24M | -28.27M | -29.12M | -28.59M | -27.82M | -21.88M | -14.56M | -14.42M |
Interest Income | 3.4M | 3.84M | 3.23M | 2.51M | 1.7M | 1.68M | 1.66M | 1.41M | 1.01M | 605K | 313K | 127K | 869K | 864K | 929K | 966K | 155K |
Pretax Income | -47.52M | -46.36M | -41.63M | -35.39M | -31.37M | -30.04M | -28.77M | -28.5M | -28.74M | -28.32M | -28.66M | -29.74M | -28.51M | -27.81M | -21.99M | -14.88M | -15.8M |
Net Income | -47.52M | -46.36M | -41.63M | -35.39M | -31.37M | -29.99M | -28.73M | -28.44M | -28.77M | -28.39M | -28.73M | -29.82M | -28.51M | -27.81M | -22M | -14.89M | -15.81M |
Selling & General & Admin | 15.59M | 14.65M | 13.1M | 11.87M | 10.28M | 9.94M | 9.64M | 9.26M | 9.38M | 9.83M | 10.16M | 10.41M | 10.43M | 10.02M | 9.55M | 9.1M | 8.87M |
Research & Development | 36.08M | 35.3M | 31.33M | 25.48M | 22.21M | 21.1M | 20.1M | 19.92M | 19.66M | 18.41M | 18.11M | 18.71M | 18.15M | 17.79M | 17.34M | 15.46M | 15.55M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -173K | -173K | -173K | -388K | -501K | -501K | -501K |
Operating Expenses | 51.66M | 49.95M | 44.43M | 37.35M | 32.49M | 31.03M | 29.74M | 29.18M | 29.04M | 28.24M | 28.27M | 29.12M | 28.59M | 27.82M | 26.88M | 24.56M | 24.42M |
Interest Expense | 59K | 157K | 258K | 390K | 500K | 604K | 686K | 724K | 718K | 688K | 706K | 741K | 795K | 856K | 1.03M | 1.29M | 1.53M |
Selling & Marketing Expenses | -20K | -20K | -40K | -40K | -20K | -20K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.47M | 50.3M | 44.6M | 37.51M | 32.57M | 31.11M | 29.74M | 29.18M | 29.04M | 28.24M | 28.27M | 29.12M | 28.59M | 27.82M | 26.88M | 24.56M | 24.42M |
Income Tax Expense | 1K | -80K | -80K | -136K | -136K | -100K | -99K | -55K | 27K | 73K | 72K | 85K | 3K | 2K | 9K | 9K | 18K |
Shares Outstanding (Basic) | 66.17M | 65.5M | 65.47M | 64.47M | 28.75M | 20.22M | 19.63M | 19.1M | 16.84M | 16.84M | 14.97M | 14.61M | 14.6M | 10.69M | 8.7M | 7.72M | 7.13M |
Shares Outstanding (Diluted) | 66.17M | 65.5M | 65.47M | 64.47M | 28.75M | 20.22M | 19.63M | 19.1M | 16.84M | 16.84M | 14.97M | 14.61M | 14.6M | 10.69M | 8.7M | 7.72M | 7.13M |
EPS (Basic) | -0.73 | -0.87 | -1.07 | -1.26 | -1.46 | -1.59 | -1.59 | -1.69 | -1.82 | -1.86 | -2.13 | -2.62 | -2.9 | -3.28 | -2.89 | -2.3 | -3.85 |
EPS (Diluted) | -0.73 | -0.87 | -1.07 | -1.26 | -1.46 | -1.59 | -1.59 | -1.69 | -1.82 | -1.86 | -2.13 | -2.62 | -2.9 | -3.28 | -2.89 | -2.3 | -3.85 |
EBITDA | -48.08M | -45.85M | -41.03M | -34.7M | -30.61M | -29.2M | -27.9M | -27.61M | -27.88M | -27.51M | -27.86M | -28.9M | -27.61M | -26.53M | -20.43M | -12.99M | -13.59M |
EBIT | -37.81M | -46.2M | -41.37M | -35M | -30.87M | -29.43M | -28.08M | -27.77M | -28.02M | -27.63M | -27.95M | -29M | -27.72M | -26.95M | -20.95M | -13.59M | -14.26M |
Depreciation & Amortization | 266K | 347K | 336K | 302K | 260K | 227K | 184K | 160K | 144K | 122K | 130K | 136K | 150K | 459K | 523K | 599K | 676K |